HomeCompareMDP vs PFE

MDP vs PFE: Dividend Comparison 2026

MDP yields 45.09% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $22.6K in total portfolio value· pulled ahead in Year 9
10 years
MDP
MDP
● Live price
45.09%
Share price
$59.07
Annual div
$26.63
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.5K
Annual income
$6.37
Full MDP calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — MDP vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDPPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDP + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDP pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDP
Annual income on $10K today (after 15% tax)
$3,832.63/yr
After 10yr DRIP, annual income (after tax)
$5.41/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, PFE beats the other by $23,123.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDP + PFE for your $10,000?

MDP: 50%PFE: 50%
100% PFE50/50100% MDP
Portfolio after 10yr
$39.8K
Annual income
$13,608.46/yr
Blended yield
34.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

MDP
Analyst Ratings
3
Buy
9
Hold
Consensus: Hold
Altman Z
1.4
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDP buys
0
PFE buys
0
No recent congressional trades found for MDP or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDPPFE
Forward yield45.09%6.20%
Annual dividend / share$26.63$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%13.2%
Portfolio after 10y$28.5K$51.1K
Annual income after 10y$6.37$27,210.54
Total dividends collected$5.2K$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldHold

Year-by-year: MDP vs PFE ($10,000, DRIP)

YearMDP PortfolioMDP Income/yrPFE PortfolioPFE Income/yrGap
1$12,954$2,254.49$9,161$701.38+$3.8KMDP
2$15,226$1,364.75$8,610$859.79+$6.6KMDP
3$17,041$749.56$8,366$1,081.25+$8.7KMDP
4$18,626$392.02$8,483$1,405.66+$10.1KMDP
5$20,130$200.23$9,084$1,907.24+$11.0KMDP
6$21,641$101.12$10,418$2,732.78+$11.2KMDP
7$23,206$50.80$13,007$4,193.56+$10.2KMDP
8$24,856$25.45$18,010$7,005.87+$6.8KMDP
9← crossover$26,609$12.74$28,216$12,979.89$1.6KPFE
10$28,478$6.37$51,081$27,210.54$22.6KPFE

MDP vs PFE: Complete Analysis 2026

MDPStock

Meredith Corporation operates as a diversified media company primarily in the United States. It operates in two segments, National Media and Local Media. The National Media segment offers national consumer media brands through various media platforms, including print magazines, digital and mobile media, brand licensing activities, database-related activities, affinity marketing, and business-to-business marketing products and services. It publishes media in entertainment, food, lifestyle, parenting, and home categories, such as People, Better Homes & Gardens, InStyle, Allrecipes, Real Simple, Shape, Southern Living, Martha Stewart Living, and other brands, as well as 300 special interest publications under approximately 70 brands. This segment operates approximately 50 Websites and applications. It is also involved in the brand licensing, affinity marketing, third-party marketing, consumer database, and other related operations, as well as provision of magazine advertising and circulation, digital and customer relationship marketing, other custom publishing project, and ancillary products and services. In addition, this segment operates The Foundry 360, a creative content studio, which develops content marketing programs across various platforms comprising native advertising that enable clients to engage new consumers and build long-term relationships with existing customers for a range of industries. The Local Media segment operates approximately 17 television stations that include 7 CBS affiliates, 5 FOX affiliates, 2 MyNetworkTV affiliates, 1 NBC affiliate, 1 ABC affiliate, and 2 independent stations. It also includes 12 Websites and 12 applications focused on news, sports, and weather-related information. In addition, this segment sells geographic and demographic-targeted digital and print advertising programs to third parties. The company was founded in 1902 and is headquartered in Des Moines, Iowa.

Full MDP Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this MDP vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDP vs SCHDMDP vs JEPIMDP vs OMDP vs KOMDP vs MAINMDP vs JNJMDP vs MRKMDP vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.